FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Virol / Evidence that Equine rhinitis A virus VP1 is a target of neu...
Journal of virology2001; 75(19); 9274-9281; doi: 10.1128/JVI.75.19.9274-9281.2001

Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding.

Abstract: Equine rhinitis A virus (ERAV) is a respiratory pathogen of horses and is classified as an Aphthovirus, the only non-Foot-and-mouth disease virus (FMDV) member of this genus. In FMDV, virion protein 1 (VP1) is a major target of protective antibodies and is responsible for viral attachment to permissive cells via an RGD motif located in a distal surface loop. Although both viruses share considerable sequence identity, ERAV VP1 does not contain an RGD motif. To investigate antibody and receptor-binding properties of ERAV VP1, we have expressed full-length ERAV VP1 in Escherichia coli as a glutathione S-transferase (GST) fusion protein (GST-VP1). GST-VP1 reacted specifically with antibodies present in serum from a rabbit immunized with purified ERAV virions and also in convalescent-phase sera from horses experimentally infected with ERAV. An antiserum raised in rabbits to GST-VP1 reacted strongly with viral VP1 and effectively neutralized ERAV infection in vitro. Using a flow cytometry-based binding assay, we found that GST-VP1, but not other GST fusion proteins, bound to cell surface receptors. This binding was reduced in a dose-dependent manner by the addition of purified ERAV virions, demonstrating the specificity of this interaction. A separate cell-binding assay also implicated GST-VP1 in receptor binding. Importantly, anti-GST-VP1 antibodies inhibited the binding of ERAV virions to Vero cells, suggesting that these antibodies exert their neutralizing effect by blocking viral attachment. Thus ERAV VP1, like its counterpart in FMDV, appears to be both a target of protective antibodies and involved directly in receptor binding. This study reveals the potential of recombinant VP1 molecules to serve as vaccines and diagnostic reagents for the control of ERAV infections.
Get Full Text
Publication Date: 2001-09-05 PubMed ID: 11533189PubMed Central: PMC114494DOI: 10.1128/JVI.75.19.9274-9281.2001Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article looks into the role of the VP1 protein in the Equine rhinitis A virus (ERAV), particularly its function as a target for neutralizing antibodies and its involvement in receptor binding. The experiment used GST-VP1, a VP1 protein expressed in Escherichia coli, and found it to bind specifically to cell surface receptors, confirming its crucial part in the infection process and suggesting its potential use as a component for vaccines and diagnostic reagents.

Background

  • The study begins by establishing the context, noting that ERAV is a respiratory pathogen impacting horses and is the only non-Foot-and-mouth disease virus (FMDV) in the Aphthovirus genus.
  • In FMDV, the VP1 protein is a primary target of protective antibodies which neutralize the virus and also aids the virus when connecting to permissive cells.
  • The difference between ERAV and FMDV is pointed out, as ERAV VP1 does not contain an RGD motif, which is important for virus-cell attachment in FMDV.

Methodology

  • The researchers cultivated full-length ERAV VP1 in the bacteria Escherichia coli to form a fusion protein called GST-VP1.
  • This protein was subjected to the antibodies from a rabbit immunized with purified ERAV virions and convalescent-phase sera from horses infected experimentally with ERAV.
  • The researchers then raised an antiserum in rabbits to GST-VP1, which reacted strongly with viral VP1 and was capable of neutralizing ERAV infection in a laboratory setting.
  • To explore the receptor-binding properties of ERAV VP1, a flow cytometry-based binding assay was employed, finding that GST-VP1 bound to cell surface receptors.

Results

  • The GST-VP1 displayed specific binding to cell surface receptors, and when doses of purified ERAV virions were added, this binding decreased, showing the specificity of the interaction.
  • Another assay suggested that GST-VP1 has a role in receptor binding as well.
  • Critical to the study’s conclusion, antibodies against GST-VP1 prevented ERAV virions from binding to Vero cells, implying these antibodies impeded viral attachment and thus could neutralize the virus.

Conclusion

  • This study suggests that ERAV VP1 behaves much like its counterpart in FMDV, acting as a target for protective antibodies and participating directly in receptor binding.
  • Notably, it puts forward the potential use of recombinant VP1 molecules as vaccines or diagnostic tools for managing ERAV infections.

Cite This Article

APA
Warner S, Hartley CA, Stevenson RA, Ficorilli N, Varrasso A, Studdert MJ, Crabb BS. (2001). Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding. J Virol, 75(19), 9274-9281. https://doi.org/10.1128/JVI.75.19.9274-9281.2001

Publication

Journal of virology
ISSN: 0022-538X
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 75
Issue: 19
Pages: 9274-9281

Researcher Affiliations

Warner, S
  • Department of Microbiology and Immunology and the Co-Operative Research Centre for Vaccine Technology, The University of Melbourne, Victoria 3010, Australia.
Hartley, C A
    Stevenson, R A
      Ficorilli, N
        Varrasso, A
          Studdert, M J
            Crabb, B S

              MeSH Terms

              • Animals
              • Antibodies, Viral / immunology
              • Antibody Specificity
              • Capsid / immunology
              • Capsid Proteins
              • Chlorocebus aethiops
              • Picornaviridae / physiology
              • Picornaviridae Infections / immunology
              • Picornaviridae Infections / virology
              • Rabbits
              • Receptors, Virus / immunology
              • Vero Cells
              • Viral Proteins / immunology
              • Virus Replication

              References

              This article includes 34 references
              1. Baranowski E, Ruiz-Jarabo CM, Sevilla N, Andreu D, Beck E, Domingo E. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.. J Virol 2000 Feb;74(4):1641-7.
                pmc: PMC111638pubmed: 10644333doi: 10.1128/jvi.74.4.1641-1647.2000google scholar: lookup
              2. Berinstein A, Roivainen M, Hovi T, Mason PW, Baxt B. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells.. J Virol 1995 Apr;69(4):2664-6.
                pmc: PMC188951pubmed: 7533862doi: 10.1128/jvi.69.4.2664-2666.1995google scholar: lookup
              3. Brown F. Antibody recognition and neutralisation of foot-and-mouth disease virus. Semin Virol 1995;6:243–248.
              4. Brown F. New approaches to vaccination against foot-and-mouth disease.. Vaccine 1992;10(14):1022-6.
                pubmed: 1335197doi: 10.1016/0264-410x(92)90111-vgoogle scholar: lookup
              5. Carman S, Rosendal S, Huber L, Gyles C, McKee S, Willoughby RA, Dubovi E, Thorsen J, Lein D. Infectious agents in acute respiratory disease in horses in Ontario.. J Vet Diagn Invest 1997 Jan;9(1):17-23.
                pubmed: 9087920doi: 10.1177/104063879700900104google scholar: lookup
              6. Coulson BS, Londrigan SL, Lee DJ. Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells.. Proc Natl Acad Sci U S A 1997 May 13;94(10):5389-94.
                pmc: PMC24688pubmed: 9144247doi: 10.1073/pnas.94.10.5389google scholar: lookup
              7. DITCHFIELD J, MACPHERSON LW. THE PROPERTIES AND CLASSIFICATION OF TWO NEW RHINOVIRUSES RECOVERED FROM HORSES IN TORONTO, CANADA.. Cornell Vet 1965 Apr;55:181-9.
                pubmed: 14317475
              8. Donnelly ML, Gani D, Flint M, Monaghan S, Ryan MD. The cleavage activities of aphthovirus and cardiovirus 2A proteins.. J Gen Virol 1997 Jan;78 ( Pt 1):13-21.
                pubmed: 9010280doi: 10.1099/0022-1317-78-1-13google scholar: lookup
              9. Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).. J Gen Virol 1989 Mar;70 ( Pt 3):625-37.
                pubmed: 2543752doi: 10.1099/0022-1317-70-3-625google scholar: lookup
              10. Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.. EMBO J 1999 Feb 1;18(3):543-54.
                pmc: PMC1171147pubmed: 9927414doi: 10.1093/emboj/18.3.543google scholar: lookup
              11. Hartley CA, Ficorilli N, Dynon K, Drummer HE, Huang JA, Studdert MJ. Equine rhinitis A virus: structural proteins and immune response.. J Gen Virol 2001 Jul;82(Pt 7):1725-1728.
                pubmed: 11413384doi: 10.1099/0022-1317-82-7-1725google scholar: lookup
              12. Hernández J, Valero ML, Andreu D, Domingo E, Mateu MG. Antibody and host cell recognition of foot-and-mouth disease virus (serotype C) cleaved at the Arg-Gly-Asp (RGD) motif: a structural interpretation.. J Gen Virol 1996 Feb;77 ( Pt 2 ):257-64.
                pubmed: 8627229doi: 10.1099/0022-1317-77-2-257google scholar: lookup
              13. Hewat EA, Verdaguer N, Fita I, Blakemore W, Brookes S, King A, Newman J, Domingo E, Mateu MG, Stuart DI. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.. EMBO J 1997 Apr 1;16(7):1492-500.
                pmc: PMC1169753pubmed: 9130694doi: 10.1093/emboj/16.7.1492google scholar: lookup
              14. Hinton TM, Li F, Crabb BS. Internal ribosomal entry site-mediated translation initiation in equine rhinitis A virus: similarities to and differences from that of foot-and-mouth disease virus.. J Virol 2000 Dec;74(24):11708-16.
                pmc: PMC112453pubmed: 11090170doi: 10.1128/jvi.74.24.11708-11716.2000google scholar: lookup
              15. Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.. J Virol 1996 Aug;70(8):5282-7.
                pmc: PMC190485pubmed: 8764038doi: 10.1128/jvi.70.8.5282-5287.1996google scholar: lookup
              16. Jackson T, Sheppard D, Denyer M, Blakemore W, King AM. The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus.. J Virol 2000 Jun;74(11):4949-56.
                pmc: PMC110846pubmed: 10799568doi: 10.1128/jvi.74.11.4949-4956.2000google scholar: lookup
              17. Li F, Browning GF, Studdert MJ, Crabb BS. Equine rhinovirus 1 is more closely related to foot-and-mouth disease virus than to other picornaviruses.. Proc Natl Acad Sci U S A 1996 Feb 6;93(3):990-5.
                pmc: PMC40017pubmed: 8577774doi: 10.1073/pnas.93.3.990google scholar: lookup
              18. Li F, Drummer HE, Ficorilli N, Studdert MJ, Crabb BS. Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses.. J Clin Microbiol 1997 Apr;35(4):937-43.
                pmc: PMC229704pubmed: 9157156doi: 10.1128/jcm.35.4.937-943.1997google scholar: lookup
              19. Londrigan SL, Hewish MJ, Thomson MJ, Sanders GM, Mustafa H, Coulson BS. Growth of rotaviruses in continuous human and monkey cell lines that vary in their expression of integrins.. J Gen Virol 2000 Sep;81(Pt 9):2203-2213.
                pubmed: 10950978doi: 10.1099/0022-1317-81-9-2203google scholar: lookup
              20. Mateu MG, Martínez MA, Capucci L, Andreu D, Giralt E, Sobrino F, Brocchi E, Domingo E. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.. J Gen Virol 1990 Mar;71 ( Pt 3):629-37.
                pubmed: 1690261doi: 10.1099/0022-1317-71-3-629google scholar: lookup
              21. McCollum W H, Timoney P J. Studies of the seroprevalence and frequency of equine rhinovirus-I and -II infection in normal horses. In: Plowright W, Rossdale P D, Wade J F, editors. Equine infectious diseases VI: Proceedings of the Sixth International Conference, 7–11 July 1991. Newmarket, United Kingdom: R & W Publications; 1992. pp. 83–87.
              22. Neff S, Sá-Carvalho D, Rieder E, Mason PW, Blystone SD, Brown EJ, Baxt B. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.. J Virol 1998 May;72(5):3587-94.
                pmc: PMC109579pubmed: 9557639doi: 10.1128/jvi.72.5.3587-3594.1998google scholar: lookup
              23. Newman JF, Rowlands DJ, Brown F. A physico-chemical sub-grouping of the mammalian picornaviruses.. J Gen Virol 1973 Feb;18(2):171-80.
                pubmed: 4351695doi: 10.1099/0022-1317-18-2-171google scholar: lookup
              24. PLUMMER G. An equine respiratory enterovirus. Some biological and physical properties.. Arch Gesamte Virusforsch 1963 Spring-Fall;12:694-700.
                pubmed: 13944113doi: 10.1007/bf01246390google scholar: lookup
              25. PLUMMER G. An equine respiratory virus with enterovirus properties.. Nature 1962 Aug 4;195:519-20.
                pubmed: 14487261doi: 10.1038/195519a0google scholar: lookup
              26. Pringle C R. Virus taxonomy 1997. Arch Virol 1997;142:1727–1733.
              27. Rueckert R R. Picornaviridae: the viruses and their replication. In: Field B N, Knipe D M, Howley P M, editors. Fields virology. 3rd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1996. pp. 609–654.
              28. Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen.. J Biol Chem 1991 Apr 25;266(12):7363-7.
                pubmed: 2019571
              29. Stanway G. Structure, function and evolution of picornaviruses.. J Gen Virol 1990 Nov;71 ( Pt 11):2483-501.
                pubmed: 2254747doi: 10.1099/0022-1317-71-11-2483google scholar: lookup
              30. Studdert M J. Equine rhinovirus infections. In: Studdert M J, editor. Virus infections of equines. Vol. 6. Amsterdam, The Netherlands: Elsevier; 1996. pp. 213–217.
              31. Studdert MJ, Gleeson LJ. Isolation and characterisation of an equine rhinovirus.. Zentralbl Veterinarmed B 1978;25(3):225-37.
                pubmed: 207059doi: 10.1111/j.1439-0450.1978.tb01180.xgoogle scholar: lookup
              32. Verdaguer N, Mateu MG, Andreu D, Giralt E, Domingo E, Fita I. Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction.. EMBO J 1995 Apr 18;14(8):1690-6.
                pmc: PMC398262pubmed: 7537661doi: 10.1002/j.1460-2075.1995.tb07158.xgoogle scholar: lookup
              33. Wasserman K, Subklewe M, Pothoff G, Banik N, Schell-Frederick E. Expression of surface markers on alveolar macrophages from symptomatic patients with HIV infection as detected by flow cytometry.. Chest 1994 May;105(5):1324-34.
                pubmed: 8181314doi: 10.1378/chest.105.5.1324google scholar: lookup
              34. Wutz G, Auer H, Nowotny N, Grosse B, Skern T, Kuechler E. Equine rhinovirus serotypes 1 and 2: relationship to each other and to aphthoviruses and cardioviruses.. J Gen Virol 1996 Aug;77 ( Pt 8):1719-30.
                pubmed: 8760418doi: 10.1099/0022-1317-77-8-1719google scholar: lookup

              Citations

              This article has been cited 8 times.
              1. Cottingham E, Johnstone T, Hartley CA, Devlin JM. Update on feline alphaherpesvirus-1 seroprevalence in Victorian feral and owned cats.. Aust Vet J 2022 May;100(5):187-189.
                doi: 10.1111/avj.13147pubmed: 35080011google scholar: lookup
              2. Mohammadifar E, Ahmadi V, Gholami MF, Oehrl A, Kolyvushko O, Nie C, Donskyi IS, Herziger S, Radnik J, Ludwig K, Böttcher C, Rabe JP, Osterrieder K, Azab W, Haag R, Adeli M. Graphene-Assisted Synthesis of 2D Polyglycerols as Innovative Platforms for Multivalent Virus Interactions.. Adv Funct Mater 2021 May 26;31(22):2009003.
                doi: 10.1002/adfm.202009003pubmed: 34230823google scholar: lookup
              3. Fleming FE, Böhm R, Dang VT, Holloway G, Haselhorst T, Madge PD, Deveryshetty J, Yu X, Blanchard H, von Itzstein M, Coulson BS. Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection.. J Virol 2014 Apr;88(8):4558-71.
                doi: 10.1128/JVI.03431-13pubmed: 24501414google scholar: lookup
              4. Diaz-Méndez A, Viel L, Shewen P, Nagy E. Genomic analysis of a Canadian equine rhinitis A virus reveals low diversity among field isolates.. Virus Genes 2013 Apr;46(2):280-6.
                doi: 10.1007/s11262-012-0848-0pubmed: 23180486google scholar: lookup
              5. Tuthill TJ, Groppelli E, Hogle JM, Rowlands DJ. Picornaviruses.. Curr Top Microbiol Immunol 2010;343:43-89.
                doi: 10.1007/82_2010_37pubmed: 20397067google scholar: lookup
              6. Li F, Stevenson RA, Crabb BS, Studdert MJ, Hartley CA. Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens.. Clin Diagn Lab Immunol 2005 Jun;12(6):778-85.
                doi: 10.1128/CDLI.12.6.778-785.2005pubmed: 15939754google scholar: lookup
              7. McSweeney LA, Dreyfus LA. Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits.. Infect Immun 2005 Apr;73(4):2051-60.
                doi: 10.1128/IAI.73.4.2051-2060.2005pubmed: 15784546google scholar: lookup
              8. Govindasamy L, Hr K, Parrish CR, Agbandje-McKenna M. Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants.. J Virol 2003 Nov;77(22):12211-21.
                doi: 10.1128/jvi.77.22.12211-12221.2003pubmed: 14581558google scholar: lookup
              Subscribe to our newsletter
              Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.